Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Participate at the Planet MicroCap Showcase

Key Takeaway: electroCore, Inc. has announced its participation in the Planet MicroCap Showcase, scheduled for April 23-24, 2025, at the Paris Hotel & Casino in Las Vegas. Dan Goldberger, the CEO, will host a group presentation and conduct one-on-one meetings with investors. This event highlights the company's commitment to its bioelectronic medicine and wellness technology, specifically non-invasive vagus nerve stimulation. Interested investors are encouraged to reach out to schedule meetings with the management.
Price reaction · baseline $6.21 (2025-04-15 close) · hit after-hours · clean, no other ECOR news in the window
day 0 close · peak
-3.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable industry event signifies company visibility.
  • Opportunity for one-on-one investor meetings with leadership.
  • Focus on innovative bioelectronic medicine and wellness solutions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet MicroCap Showcase taking place at the Paris Hotel & Casino in Las Vegas on April 23 & 24, 2025.
Dan Goldberger, CEO, will host a group presentation on Wednesday, April 23, 2025 at 1:30 p.m. PT and host one-on-one meetings throughout both days.
To schedule a one-on-one meeting with Mr. Goldberger, investors are encouraged to reach out to Planet MicroCap or electroCore’s investor relations at ecor@fnkir.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When is the Planet MicroCap Showcase event?

The event occurs on April 23 & 24, 2025.

Who will represent electroCore at the Showcase?

Dan Goldberger, CEO, will represent electroCore.

How can investors schedule a meeting with Dan Goldberger?

Investors can schedule meetings by contacting Planet MicroCap or electroCore’s investor relations.

What technology does electroCore use?

electroCore utilizes non-invasive vagus nerve stimulation (nVNS) technology.

What is the focus of electroCore, Inc.?

The focus is on commercializing nVNS medical devices and wellness products.

Last updated: Apr 16, 2025